Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban

WHAT IS KNOWN AND OBJECTIVE: Edoxaban has three dose adjustment factors (creatinine clearance, 15‐50 mL/min; body weight, 60 kg or less; and concomitant medication with potent P‐glycoprotein inhibitors) to prevent bleeding that results from elevated blood concentrations of the drug. A dose reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Takase, Tomoki, Ikesue, Hiroaki, Nakagawa, Haruna, Kinoshita, Megumi, Muroi, Nobuyuki, Kitai, Takeshi, Furukawa, Yutaka, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079038/
https://www.ncbi.nlm.nih.gov/pubmed/31602680
http://dx.doi.org/10.1111/jcpt.13065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079038/
https://www.ncbi.nlm.nih.gov/pubmed/31602680
http://dx.doi.org/10.1111/jcpt.13065

Ejemplares similares